Part Number: NDC00591-3213-72 | Manufacturer: Actavis Pharma Inc | NSN: 6505-01-656-4667 (6505016564667) | |
Item Name: fentanyl transdermal system | CAGE Code: 6LMB8 | ||
Alternate P/N : NDC00591321372 |
Please utilize the RFQ form below to submit an online quote request for NSN part number NDC00591-3213-72 of Fentanyl Transdermal System by manufacturer Actavis Pharma Inc having CAGE Code 6LMB8 with NSN number 6505-01-656-4667. Please also fill the requested quantity and need by date form fields for your required part NDC00591-3213-72. This information will help us prioritize your request effectively.
“*” Symbols for mandatory fields
Aerospace Orbit is owned and operated by ASAP Semiconductor – an AS9120B, ISO 9001:2015, and FAA AC 00-56B distributor of Actavis Pharma Inc NSN parts. We stock difficult-to-find parts from more than 75,000 manufacturers. Request a quote for part number NDC00591-3213-72 and an account manager will contact you shortly.
Our industry relationships allow us to assure competitive prices on all obsolete parts, and shorten the supply chain to deliver as soon as possible. You will receive a response within 15 minutes from a sales representative at Aerospace Orbit. Additionally, you can call us at +1-714-705-4780 or submit a Bill of Materials (BOM) to sales@aerospaceorbit.com to expedite the purchase process.
NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
---|---|---|---|---|---|---|
6505-01-656-4667 Item Description: Fentanyl Transdermal System | 6505 | 016564667 | M | P | ||
CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
R | A | 0 | ||||
Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
Ndc00591-3213-72 | 5 | 2 | 3 |
MRC | Criteria | Characteristic |
---|---|---|
FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
CSLZ | Usual Dose | 75 MCG/HR |
CBBL | Features Provided | INDIVIDUALLY SEALED |
CRYC | Controlled Substance Classification | SCHEDULE II |
CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S |
MRC | Decoded Requirement | Clear Text Reply |
Please Remember to Visit Us Again the Next Time You Need Parts.
Request for Quote